Antibody epitope profiling of the KSHV LANA protein using VirScan

Authors

Sydney J. Bennett, University of Nebraska-Lincoln, Louisiana State University Health Sciences CenterFollow
Dicle Yalcin, Louisiana State University Health Sciences Center
Sara R. Privatt, University of Nebraska-Lincoln, Louisiana State University Health Sciences Center
Owen Ngalamika, University of Zambia School of Medicine
Salum J. Lidenge, Ocean Road Cancer Institute, Muhimbili University of Health and Allied Sciences
John T. West, , Louisiana State University Health Sciences Center
Charles Wood, University of Nebraska-Lincoln, Louisiana State University Health Sciences Center

Document Type

Article

Date of this Version

12-19-2022

Citation

Bennett SJ, Yalcin D, Privatt SR, Ngalamika O, Lidenge SJ, West JT, et al. (2022) Antibody epitope profiling of the KSHV LANA protein using VirScan. PLoS Pathog 18(12): e1011033. https://doi.org/10.1371/journal. ppat.1011033

Comments

Open access.

Abstract

The humoral antibody response against Kaposi sarcoma-associated herpesvirus (KSHV) in infected individuals has been characterized demonstrating the latency-associated nuclear antigen (LANA) as the most antigenic KSHV protein. Despite the antigenicity of the protein, specific LANA epitopes have not been systematically characterized. Here, we utilized a bacteriophage T7 library, which displays 56-amino acid KSHV LANA peptides with 28-amino acid overlap (VirScan), to define those epitopes in LANA targeted by antibodies from a cohort of 62 sub-Saharan African Kaposi sarcoma (KS) patients and 22 KSHV-infected asymptomatic controls. Intra- and inter-patient breadth and magnitude of the anti-LANA responses were quantified at the peptide and amino acid levels. From these data, we derived a detailed epitope annotation of the entire LANA protein, with a high-resolution focus on the N- and C-termini. Overall, the central repeat region was highly antigenic, but the responses to this region could not be confidently mapped due to its high variability. The highly conserved N-terminus was targeted with low breadth and magnitude. In a minority of individuals, antibodies specific to the nuclear localization sequence and a portion of the proline-rich regions of the N-terminus were evident. In contrast, the first half of the conserved C-terminal domain was consistently targeted with high magnitude. Unfortunately, this region was not included in LANA partial C-terminal crystal structures, however, it was predicted to adopt predominantly random-coil structure. Coupled with functional and secondary structure domain predictions, VirScan revealed fine resolution epitope mapping of the N- and C-terminal domains of LANA that is consistent with previous antigenicity studies and may prove useful to correlate KSHV humoral immunity with pathogenesis.